イオプロミドAPIのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Iopromide API Market Insights, Forecast to 2028

• レポートコード：QY2207E00233 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、75ページ • 納品方法：Eメール（納期：3日） • 産業分類：自動車＆輸送

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界のイオプロミドAPIの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にイオプロミドAPIの世界市場のxxx％を占める「原薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のイオプロミドAPIの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのイオプロミドAPI市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのイオプロミドAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 イオプロミドAPIのグローバル主要メーカーには、Bayer、Stellite、Haichang Pharmaceuticalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 イオプロミドAPI市場は、種類と用途によって区分されます。世界のイオプロミドAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 原薬、ジェネリック医薬品 【用途別セグメント】 病院、クリニック 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - イオプロミドAPI製品概要 - 種類別市場（原薬、ジェネリック医薬品） - 用途別市場（病院、クリニック） - 調査の目的 ・エグゼクティブサマリー - 世界のイオプロミドAPI販売量予測2017-2028 - 世界のイオプロミドAPI売上予測2017-2028 - イオプロミドAPIの地域別販売量 - イオプロミドAPIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別イオプロミドAPI販売量 - 主要メーカー別イオプロミドAPI売上 - 主要メーカー別イオプロミドAPI価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（原薬、ジェネリック医薬品） - イオプロミドAPIの種類別販売量 - イオプロミドAPIの種類別売上 - イオプロミドAPIの種類別価格 ・用途別市場規模（病院、クリニック） - イオプロミドAPIの用途別販売量 - イオプロミドAPIの用途別売上 - イオプロミドAPIの用途別価格 ・北米市場 - 北米のイオプロミドAPI市場規模（種類別、用途別） - 主要国別のイオプロミドAPI市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのイオプロミドAPI市場規模（種類別、用途別） - 主要国別のイオプロミドAPI市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のイオプロミドAPI市場規模（種類別、用途別） - 主要国別のイオプロミドAPI市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のイオプロミドAPI市場規模（種類別、用途別） - 主要国別のイオプロミドAPI市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのイオプロミドAPI市場規模（種類別、用途別） - 主要国別のイオプロミドAPI市場規模（トルコ、サウジアラビア） ・企業情報 Bayer、Stellite、Haichang Pharmaceutical ・産業チェーン及び販売チャネル分析 - イオプロミドAPIの産業チェーン分析 - イオプロミドAPIの原材料 - イオプロミドAPIの生産プロセス - イオプロミドAPIの販売及びマーケティング - イオプロミドAPIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - イオプロミドAPIの産業動向 - イオプロミドAPIのマーケットドライバー - イオプロミドAPIの課題 - イオプロミドAPIの阻害要因 ・主な調査結果

Iopromide is a new type of non-ionic hypotonic contrast agent, and animal experiments have shown that it is suitable for angiography, brain and abdominal CT scans, and urethrography.
Market Analysis and Insights: Global Iopromide API Market
Due to the COVID-19 pandemic, the global Iopromide API market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Original Drug accounting for % of the Iopromide API global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Iopromide API market size is valued at US$ million in 2021, while the US and Europe Iopromide API are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Iopromide API landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Iopromide API include Bayer, Stellite and Haichang Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Iopromide API capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Iopromide API by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Iopromide API Scope and Segment
Iopromide API market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Iopromide API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Original Drug
Generic Drug
Segment by Application
Hospitals
Clinics
By Company
Bayer
Stellite
Haichang Pharmaceutical
Production by Region
North America
Europe
China
Japan
South Korea
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Iopromide API Product Introduction
1.2 Market by Type
1.2.1 Global Iopromide API Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Iopromide API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Iopromide API Production
2.1 Global Iopromide API Production Capacity (2017-2028)
2.2 Global Iopromide API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Iopromide API Production by Region
2.3.1 Global Iopromide API Historic Production by Region (2017-2022)
2.3.2 Global Iopromide API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 South Korea
2.9 India
3 Global Iopromide API Sales in Volume & Value Estimates and Forecasts
3.1 Global Iopromide API Sales Estimates and Forecasts 2017-2028
3.2 Global Iopromide API Revenue Estimates and Forecasts 2017-2028
3.3 Global Iopromide API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Iopromide API Sales by Region
3.4.1 Global Iopromide API Sales by Region (2017-2022)
3.4.2 Global Sales Iopromide API by Region (2023-2028)
3.5 Global Iopromide API Revenue by Region
3.5.1 Global Iopromide API Revenue by Region (2017-2022)
3.5.2 Global Iopromide API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Iopromide API Production Capacity by Manufacturers
4.2 Global Iopromide API Sales by Manufacturers
4.2.1 Global Iopromide API Sales by Manufacturers (2017-2022)
4.2.2 Global Iopromide API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Iopromide API in 2021
4.3 Global Iopromide API Revenue by Manufacturers
4.3.1 Global Iopromide API Revenue by Manufacturers (2017-2022)
4.3.2 Global Iopromide API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Iopromide API Revenue in 2021
4.4 Global Iopromide API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Iopromide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Iopromide API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Iopromide API Sales by Type
5.1.1 Global Iopromide API Historical Sales by Type (2017-2022)
5.1.2 Global Iopromide API Forecasted Sales by Type (2023-2028)
5.1.3 Global Iopromide API Sales Market Share by Type (2017-2028)
5.2 Global Iopromide API Revenue by Type
5.2.1 Global Iopromide API Historical Revenue by Type (2017-2022)
5.2.2 Global Iopromide API Forecasted Revenue by Type (2023-2028)
5.2.3 Global Iopromide API Revenue Market Share by Type (2017-2028)
5.3 Global Iopromide API Price by Type
5.3.1 Global Iopromide API Price by Type (2017-2022)
5.3.2 Global Iopromide API Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Iopromide API Sales by Application
6.1.1 Global Iopromide API Historical Sales by Application (2017-2022)
6.1.2 Global Iopromide API Forecasted Sales by Application (2023-2028)
6.1.3 Global Iopromide API Sales Market Share by Application (2017-2028)
6.2 Global Iopromide API Revenue by Application
6.2.1 Global Iopromide API Historical Revenue by Application (2017-2022)
6.2.2 Global Iopromide API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Iopromide API Revenue Market Share by Application (2017-2028)
6.3 Global Iopromide API Price by Application
6.3.1 Global Iopromide API Price by Application (2017-2022)
6.3.2 Global Iopromide API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Iopromide API Market Size by Type
7.1.1 North America Iopromide API Sales by Type (2017-2028)
7.1.2 North America Iopromide API Revenue by Type (2017-2028)
7.2 North America Iopromide API Market Size by Application
7.2.1 North America Iopromide API Sales by Application (2017-2028)
7.2.2 North America Iopromide API Revenue by Application (2017-2028)
7.3 North America Iopromide API Sales by Country
7.3.1 North America Iopromide API Sales by Country (2017-2028)
7.3.2 North America Iopromide API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Iopromide API Market Size by Type
8.1.1 Europe Iopromide API Sales by Type (2017-2028)
8.1.2 Europe Iopromide API Revenue by Type (2017-2028)
8.2 Europe Iopromide API Market Size by Application
8.2.1 Europe Iopromide API Sales by Application (2017-2028)
8.2.2 Europe Iopromide API Revenue by Application (2017-2028)
8.3 Europe Iopromide API Sales by Country
8.3.1 Europe Iopromide API Sales by Country (2017-2028)
8.3.2 Europe Iopromide API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Iopromide API Market Size by Type
9.1.1 Asia Pacific Iopromide API Sales by Type (2017-2028)
9.1.2 Asia Pacific Iopromide API Revenue by Type (2017-2028)
9.2 Asia Pacific Iopromide API Market Size by Application
9.2.1 Asia Pacific Iopromide API Sales by Application (2017-2028)
9.2.2 Asia Pacific Iopromide API Revenue by Application (2017-2028)
9.3 Asia Pacific Iopromide API Sales by Region
9.3.1 Asia Pacific Iopromide API Sales by Region (2017-2028)
9.3.2 Asia Pacific Iopromide API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Iopromide API Market Size by Type
10.1.1 Latin America Iopromide API Sales by Type (2017-2028)
10.1.2 Latin America Iopromide API Revenue by Type (2017-2028)
10.2 Latin America Iopromide API Market Size by Application
10.2.1 Latin America Iopromide API Sales by Application (2017-2028)
10.2.2 Latin America Iopromide API Revenue by Application (2017-2028)
10.3 Latin America Iopromide API Sales by Country
10.3.1 Latin America Iopromide API Sales by Country (2017-2028)
10.3.2 Latin America Iopromide API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Iopromide API Market Size by Type
11.1.1 Middle East and Africa Iopromide API Sales by Type (2017-2028)
11.1.2 Middle East and Africa Iopromide API Revenue by Type (2017-2028)
11.2 Middle East and Africa Iopromide API Market Size by Application
11.2.1 Middle East and Africa Iopromide API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Iopromide API Revenue by Application (2017-2028)
11.3 Middle East and Africa Iopromide API Sales by Country
11.3.1 Middle East and Africa Iopromide API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Iopromide API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Bayer
12.1.1 Bayer Corporation Information
12.1.2 Bayer Overview
12.1.3 Bayer Iopromide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Bayer Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Bayer Recent Developments
12.2 Stellite
12.2.1 Stellite Corporation Information
12.2.2 Stellite Overview
12.2.3 Stellite Iopromide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Stellite Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Stellite Recent Developments
12.3 Haichang Pharmaceutical
12.3.1 Haichang Pharmaceutical Corporation Information
12.3.2 Haichang Pharmaceutical Overview
12.3.3 Haichang Pharmaceutical Iopromide API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Haichang Pharmaceutical Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Haichang Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Iopromide API Industry Chain Analysis
13.2 Iopromide API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Iopromide API Production Mode & Process
13.4 Iopromide API Sales and Marketing
13.4.1 Iopromide API Sales Channels
13.4.2 Iopromide API Distributors
13.5 Iopromide API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Iopromide API Industry Trends
14.2 Iopromide API Market Drivers
14.3 Iopromide API Market Challenges
14.4 Iopromide API Market Restraints
15 Key Finding in The Global Iopromide API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Iopromide API Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Original Drug
Table 3. Major Manufacturers of Generic Drug
Table 4. Global Iopromide API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Iopromide API Production by Region: 2017 VS 2021 VS 2028 (K Units)
Table 6. Global Iopromide API Production by Region (2017-2022) & (K Units)
Table 7. Global Iopromide API Production Market Share by Region (2017-2022)
Table 8. Global Iopromide API Production by Region (2023-2028) & (K Units)
Table 9. Global Iopromide API Production Market Share by Region (2023-2028)
Table 10. Global Iopromide API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Iopromide API Sales by Region (2017-2022) & (K Units)
Table 12. Global Iopromide API Sales Market Share by Region (2017-2022)
Table 13. Global Iopromide API Sales by Region (2023-2028) & (K Units)
Table 14. Global Iopromide API Sales Market Share by Region (2023-2028)
Table 15. Global Iopromide API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Iopromide API Revenue Market Share by Region (2017-2022)
Table 17. Global Iopromide API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Iopromide API Revenue Market Share by Region (2023-2028)
Table 19. Global Iopromide API Production Capacity by Manufacturers (2017-2022) & (K Units)
Table 20. Global Iopromide API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Iopromide API Sales by Manufacturers (2017-2022) & (K Units)
Table 22. Global Iopromide API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Iopromide API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Iopromide API Revenue Share by Manufacturers (2017-2022)
Table 25. Iopromide API Price by Manufacturers 2017-2022 (US$/Unit)
Table 26. Global Iopromide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Iopromide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iopromide API as of 2021)
Table 28. Iopromide API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Iopromide API Product Offered
Table 30. Date of Manufacturers Enter into Iopromide API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Iopromide API Sales by Type (2017-2022) & (K Units)
Table 33. Global Iopromide API Sales by Type (2023-2028) & (K Units)
Table 34. Global Iopromide API Sales Share by Type (2017-2022)
Table 35. Global Iopromide API Sales Share by Type (2023-2028)
Table 36. Global Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 37. Global Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 38. Global Iopromide API Revenue Share by Type (2017-2022)
Table 39. Global Iopromide API Revenue Share by Type (2023-2028)
Table 40. Iopromide API Price by Type (2017-2022) & (US$/Unit)
Table 41. Global Iopromide API Price Forecast by Type (2023-2028) & (US$/Unit)
Table 42. Global Iopromide API Sales by Application (2017-2022) & (K Units)
Table 43. Global Iopromide API Sales by Application (2023-2028) & (K Units)
Table 44. Global Iopromide API Sales Share by Application (2017-2022)
Table 45. Global Iopromide API Sales Share by Application (2023-2028)
Table 46. Global Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Iopromide API Revenue Share by Application (2017-2022)
Table 49. Global Iopromide API Revenue Share by Application (2023-2028)
Table 50. Iopromide API Price by Application (2017-2022) & (US$/Unit)
Table 51. Global Iopromide API Price Forecast by Application (2023-2028) & (US$/Unit)
Table 52. North America Iopromide API Sales by Type (2017-2022) & (K Units)
Table 53. North America Iopromide API Sales by Type (2023-2028) & (K Units)
Table 54. North America Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 55. North America Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 56. North America Iopromide API Sales by Application (2017-2022) & (K Units)
Table 57. North America Iopromide API Sales by Application (2023-2028) & (K Units)
Table 58. North America Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Iopromide API Sales by Country (2017-2022) & (K Units)
Table 61. North America Iopromide API Sales by Country (2023-2028) & (K Units)
Table 62. North America Iopromide API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Iopromide API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Iopromide API Sales by Type (2017-2022) & (K Units)
Table 65. Europe Iopromide API Sales by Type (2023-2028) & (K Units)
Table 66. Europe Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 67. Europe Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 68. Europe Iopromide API Sales by Application (2017-2022) & (K Units)
Table 69. Europe Iopromide API Sales by Application (2023-2028) & (K Units)
Table 70. Europe Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Iopromide API Sales by Country (2017-2022) & (K Units)
Table 73. Europe Iopromide API Sales by Country (2023-2028) & (K Units)
Table 74. Europe Iopromide API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Iopromide API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Iopromide API Sales by Type (2017-2022) & (K Units)
Table 77. Asia Pacific Iopromide API Sales by Type (2023-2028) & (K Units)
Table 78. Asia Pacific Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 79. Asia Pacific Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 80. Asia Pacific Iopromide API Sales by Application (2017-2022) & (K Units)
Table 81. Asia Pacific Iopromide API Sales by Application (2023-2028) & (K Units)
Table 82. Asia Pacific Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Iopromide API Sales by Region (2017-2022) & (K Units)
Table 85. Asia Pacific Iopromide API Sales by Region (2023-2028) & (K Units)
Table 86. Asia Pacific Iopromide API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Iopromide API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Iopromide API Sales by Type (2017-2022) & (K Units)
Table 89. Latin America Iopromide API Sales by Type (2023-2028) & (K Units)
Table 90. Latin America Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 91. Latin America Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 92. Latin America Iopromide API Sales by Application (2017-2022) & (K Units)
Table 93. Latin America Iopromide API Sales by Application (2023-2028) & (K Units)
Table 94. Latin America Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Iopromide API Sales by Country (2017-2022) & (K Units)
Table 97. Latin America Iopromide API Sales by Country (2023-2028) & (K Units)
Table 98. Latin America Iopromide API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Iopromide API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Iopromide API Sales by Type (2017-2022) & (K Units)
Table 101. Middle East and Africa Iopromide API Sales by Type (2023-2028) & (K Units)
Table 102. Middle East and Africa Iopromide API Revenue by Type (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Iopromide API Revenue by Type (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Iopromide API Sales by Application (2017-2022) & (K Units)
Table 105. Middle East and Africa Iopromide API Sales by Application (2023-2028) & (K Units)
Table 106. Middle East and Africa Iopromide API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Iopromide API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Iopromide API Sales by Country (2017-2022) & (K Units)
Table 109. Middle East and Africa Iopromide API Sales by Country (2023-2028) & (K Units)
Table 110. Middle East and Africa Iopromide API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Iopromide API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Bayer Corporation Information
Table 113. Bayer Description and Major Businesses
Table 114. Bayer Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Bayer Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Recent Development
Table 117. Stellite Corporation Information
Table 118. Stellite Description and Major Businesses
Table 119. Stellite Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Stellite Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Stellite Recent Development
Table 122. Haichang Pharmaceutical Corporation Information
Table 123. Haichang Pharmaceutical Description and Major Businesses
Table 124. Haichang Pharmaceutical Iopromide API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Haichang Pharmaceutical Iopromide API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Haichang Pharmaceutical Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Iopromide API Distributors List
Table 130. Iopromide API Customers List
Table 131. Iopromide API Market Trends
Table 132. Iopromide API Market Drivers
Table 133. Iopromide API Market Challenges
Table 134. Iopromide API Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Iopromide API Product Picture
Figure 2. Global Iopromide API Market Share by Type in 2021 & 2028
Figure 3. Original Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Iopromide API Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Iopromide API Report Years Considered
Figure 9. Global Iopromide API Capacity, Production and Utilization (2017-2028) & (K Units)
Figure 10. Global Iopromide API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Iopromide API Production Market Share by Region (2017-2022)
Figure 12. Global Iopromide API Production Market Share by Region (2023-2028)
Figure 13. Iopromide API Production Growth Rate in North America (2017-2028) & (K Units)
Figure 14. Iopromide API Production Growth Rate in Europe (2017-2028) & (K Units)
Figure 15. Iopromide API Production Growth Rate in China (2017-2028) & (K Units)
Figure 16. Iopromide API Production Growth Rate in Japan (2017-2028) & (K Units)
Figure 17. Iopromide API Production Growth Rate in South Korea (2017-2028) & (K Units)
Figure 18. Iopromide API Production Growth Rate in India (2017-2028) & (K Units)
Figure 19. Global Iopromide API Sales 2017-2028 (K Units)
Figure 20. Global Iopromide API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Iopromide API Revenue 2017-2028 (US$ Million)
Figure 22. Global Iopromide API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Iopromide API Sales Market Share by Region (2017-2022)
Figure 24. Global Iopromide API Sales Market Share by Region (2023-2028)
Figure 25. North America Iopromide API Sales YoY (2017-2028) & (K Units)
Figure 26. North America Iopromide API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Iopromide API Sales YoY (2017-2028) & (K Units)
Figure 28. Europe Iopromide API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Iopromide API Sales YoY (2017-2028) & (K Units)
Figure 30. Asia-Pacific Iopromide API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Iopromide API Sales YoY (2017-2028) & (K Units)
Figure 32. Latin America Iopromide API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Iopromide API Sales YoY (2017-2028) & (K Units)
Figure 34. Middle East & Africa Iopromide API Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Iopromide API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Iopromide API in the World: Market Share by Iopromide API Revenue in 2021
Figure 37. Iopromide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Iopromide API Sales Market Share by Type (2017-2028)
Figure 39. Global Iopromide API Revenue Market Share by Type (2017-2028)
Figure 40. Global Iopromide API Sales Market Share by Application (2017-2028)
Figure 41. Global Iopromide API Revenue Market Share by Application (2017-2028)
Figure 42. North America Iopromide API Sales Market Share by Type (2017-2028)
Figure 43. North America Iopromide API Revenue Market Share by Type (2017-2028)
Figure 44. North America Iopromide API Sales Market Share by Application (2017-2028)
Figure 45. North America Iopromide API Revenue Market Share by Application (2017-2028)
Figure 46. North America Iopromide API Sales Share by Country (2017-2028)
Figure 47. North America Iopromide API Revenue Share by Country (2017-2028)
Figure 48. United States Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Iopromide API Sales Market Share by Type (2017-2028)
Figure 51. Europe Iopromide API Revenue Market Share by Type (2017-2028)
Figure 52. Europe Iopromide API Sales Market Share by Application (2017-2028)
Figure 53. Europe Iopromide API Revenue Market Share by Application (2017-2028)
Figure 54. Europe Iopromide API Sales Share by Country (2017-2028)
Figure 55. Europe Iopromide API Revenue Share by Country (2017-2028)
Figure 56. Germany Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 57. France Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Iopromide API Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Iopromide API Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Iopromide API Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Iopromide API Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Iopromide API Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Iopromide API Revenue Share by Region (2017-2028)
Figure 67. China Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 70. India Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 72. China Taiwan Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 76. Latin America Iopromide API Sales Market Share by Type (2017-2028)
Figure 77. Latin America Iopromide API Revenue Market Share by Type (2017-2028)
Figure 78. Latin America Iopromide API Sales Market Share by Application (2017-2028)
Figure 79. Latin America Iopromide API Revenue Market Share by Application (2017-2028)
Figure 80. Latin America Iopromide API Sales Share by Country (2017-2028)
Figure 81. Latin America Iopromide API Revenue Share by Country (2017-2028)
Figure 82. Mexico Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 83. Brazil Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 84. Argentina Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 85. Colombia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Iopromide API Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Iopromide API Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Iopromide API Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Iopromide API Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Iopromide API Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Iopromide API Revenue Share by Country (2017-2028)
Figure 92. Turkey Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 94. UAE Iopromide API Revenue (2017-2028) & (US$ Million)
Figure 95. Iopromide API Value Chain
Figure 96. Iopromide API Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

---